Price Chart

Profile

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
URL https://www.lilly.com
Investor Relations URL https://investor.lilly.com/
HQ State/Province Indiana
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Growth
Next Earnings Release Oct. 31, 2023
Last Earnings Release Aug. 08, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 14, 2023

Profile

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
URL https://www.lilly.com
Investor Relations URL https://investor.lilly.com/
HQ State/Province Indiana
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Growth
Next Earnings Release Oct. 31, 2023
Last Earnings Release Aug. 08, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 14, 2023